| In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
| Interest income: |
| Interest income on loans | 56.6 | 53.1 | 49.7 | 47.7 | 47.7 | 39.8 | 32.3 | 8.8 |
| Interest income on repurchase agreements | 0.3 | 0.2 | 0.2 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 |
| | 49.7 | 46.1 | 42.2 | 39.0 | 37.1 | 35.9 | 26.8 | 27.4 |
| Interest expense: |
| Interest on deposits | 13.3 | 8.9 | 5.7 | 3.9 | 3.4 | 3.4 | 2.5 | 2.6 |
| | 16.2 | 11.4 | 7.2 | 5.0 | 4.2 | 4.2 | 3.2 | 3.4 |
| Net interest income | 33.5 | 34.7 | 34.9 | 34.1 | 32.9 | 31.7 | 23.6 | 24.0 |
| Provision for loan losses | 0.5 | | | | -2.7 | -3.3 | -2.8 | |
| Net interest income after provision for loan losses | 32.9 | 34.1 | 34.8 | 36.7 | 35.6 | 34.9 | 26.4 | 24.0 |
| Deposit and loan fees | 1.0 | 1.0 | 1.1 | 1.1 | 1.2 | 1.2 | 0.8 | 0.9 |
| Other non-interest income | 8.5 | 8.9 | 9.4 | 8.4 | 9.3 | 9.3 | 7.1 | 8.4 |
| Total non-interest income | 9.5 | 9.8 | 10.4 | 9.5 | 10.4 | 10.4 | 8.0 | 9.2 |
| Non-interest expenses | 36.5 | 35.9 | 35.7 | 35.4 | 35.3 | 34.2 | 25.7 | 25.1 |
| Pre-tax income before non-recurring items | 6.4 | 8.3 | 9.7 | 9.7 | 9.9 | 11.7 | 9.0 | 10.6 |
| Non-recurring items | 1.2 | 1.0 | 0.9 | 1.1 | 1.2 | 1.2 | 1.0 | 0.9 |
| Pre-tax income | 5.3 | 7.4 | 8.8 | 8.6 | 8.7 | 10.4 | 8.0 | 9.7 |
| Income taxes | 0.0 | 0.5 | 0.5 | 0.6 | 0.7 | 1.0 | 1.1 | 1.3 |
| Tax rate | -0.9% | | 5.5% | 6.9% | 7.7% | | 13.2% | 13.8% |
| Net income | 5.3 | 6.8 | 8.3 | 8.0 | 8.0 | 9.3 | 6.8 | 8.1 |
| Net margin | 12.9% | 16.1% | 19.0% | 17.5% | 17.6% | 20.6% | 19.9% | 23.9% |
| |
| Basic EPS | $1.53 | $1.98 | $2.41 | $2.36 | $2.39 | $2.85 | $2.82 | $3.38 |
| Diluted EPS | $1.53 | $1.98 | $2.41 | $2.32 | $2.32 | $2.72 | $2.65 | $3.17 |
| |
| Shares outstanding (basic) | 3.5 | 3.5 | 3.4 | 3.4 | 3.3 | 3.3 | 2.4 | 2.4 |
| Shares outstanding (diluted) | 3.5 | 3.5 | 3.4 | 3.4 | 3.4 | 3.4 | 2.6 | 2.6 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |